Sexual Side Effects of Medications and Other Drugs
  • Jose Florante J. Leyson
  • Robert T. Francoeur


Until recently, few physicians and patients were aware that common medications can, and often do, adversely affect sexual responses. If the matter was discussed, the physician often had little if any specific information available. Before the 1980s, sexual dysfunctions of patients taking medications and recreational drugs were a minor concern for both the physician and the patient, because sex researchers/therapists reported that only 5–10% of all sexual dysfunctions were caused by organic or physical causes, whereas 90–95% were psychogenic in their origins. Today these same sex therapists have reevaluated their conclusions as a result of the recent rapid progress in sexology. It is now estimated that between 50–70% of all sexual dysfunctions have major organic or iatrogenic (i.e., drug-induced) etiologies. This new insight, coupled with growing awareness of the wide variety of potential adverse side effects associated with all medication, has raised many questions about the adverse sexual side effects of medications and drugs. The most common sexual side effects reported are reduced sexual desire in both men and women, erectile dysfunctions, and the inability to achieve orgasm in both sexes.


Erectile Dysfunction Sexual Dysfunction Sexual Arousal Autonomic Dysreflexia Female Orgasm 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bringing research into effective focus. (1983) Statistical findings at the Regional Spinal Cord System Rehab. Brief 6, 1–4.Google Scholar
  2. 2.
    Buffum, J. (1982) Pharmacosexology—The effects of drugs on sexual function. A review J. Psychoactive Drugs 14, 1, 2, 5–44.CrossRefGoogle Scholar
  3. 3.
    DeMoya, A., DeMoya, D., Lewis, M., and Lewis, H. (1982) Sex and Health. New York: Stein and Day.Google Scholar
  4. 4.
    Domer, F. R., Wessler, G., Brown, R. L., et al. (1978) Involvement of the sympathetic nervous system in urinary bladder internal sphincter and in penile erection in the anesthetized cat. Invest. Urol. 15, 404–410.PubMedGoogle Scholar
  5. 5.
    Hughes, J. M. (1964) Failure to ejaculate with chlorthiazepoxide. Am. J. Psychiatry 121, 610, 611.PubMedGoogle Scholar
  6. 6.
    Kaplan, H. S. (1979) Disorders of Sexual Desire. Bruner/Mazel, New York.Google Scholar
  7. 7.
    Leyson, J. F. J. (1981) Recent theories of male and female sexual physiology. Read at the Assoc. of Phil. Practicing Physicians in America. Anaheim, CA, Aug. 13–15.Google Scholar
  8. 8.
    Leyson, J. F. J. (1982) Sexual Options in SCI patients. Spinal Cord Injury Symposium. Kessler Institute for Rehabilitation, West Orange, NJ. April 22.Google Scholar
  9. 9.
    Leyson, J. F. J., and Manigbas, J. (1978) Use of oxybutynin in preventing autonomic dysreflexia in SCI patients. Presented at AU A Meeting, New York Section, Valentine’s Award, New York, NY, April 14.Google Scholar
  10. 10.
    Leyson, J. F. J., Stefaniwsky, L., and Martin, B. R. (1978) Phenoxyben-zamine as adjunctive treatment of hyperhidrosis in SCI patients. Read at the Am. Paraplegia Society Meeting. Annual Spinal Cord Inj. Conf. North-port, NY. Sept. 18, 19.Google Scholar
  11. 11.
    Leyson, J. F. J., Martin, B. F., and Sporer, A. (1980) Baclofen in the treatment of detrusor-sphincter dyssynergia in spinal cord injury patients. J. Urol. 124, 82–84.PubMedGoogle Scholar
  12. 12.
    McGuire, E. J., and Rossier, A. B. (1983) Treatment of acute autonomic dysreflexia. J. Urol. 129, 1185–1187.PubMedGoogle Scholar
  13. 13.
    Melman, A. (1983) Rat study shows reduced reflex in penis and propanolol use. Urology Times 11, 23.Google Scholar
  14. 14.
    Meyer, J. J., Kern, A., Godec, C. J., and Cass, A. S. (1982) The response of impotent patients to Duvoid. Presented at the Am. Urol. Assoc. Meeting. Kansas City, MO. May 16–20.Google Scholar
  15. 15.
    News Briefs (1983) OK due for ranitidine vs ulcers. Medical Tribune 24, 1.Google Scholar
  16. 16.
    Osterholm, J. L. (1976) Early management of spinal cord injury: Theory and practice. The vascular and cellular basis for spinal cord hemorrhage necrosis. In Current Controversies in Neurosurgery, Morley, T. P., ed. Philadelphia, PA, Saunders, Chap. 5.Google Scholar
  17. 17.
    Papadopoulos, C. (1980) Cardiovascular drugs and sexuality: A cardiologist’s review. Arch. Intern. Med. 140, 341.Google Scholar
  18. 18.
    Segraves, T. R. (1981) Psychopharmocological agents associated with sexual dysfunctions. J. Sex Ed. Therapy 7, 43–45.Google Scholar
  19. 19.
    Sporer, A., Leyson, J. F. J., and Martin, B. F. (1978) Effects of bethanochol chloride on the external urethral sphincter in SCI patients. J. Urol. 120, 62–65.PubMedGoogle Scholar
  20. 20.
    Tennet, G., Bancroft, J., and Cass, J. (1974) The control of deviant sexual behavior by drugs: A double-blind controlled study of benperidol, chlorpromazine and placebo. Arch. Sex. Behav. 3, 261–271.CrossRefGoogle Scholar
  21. 21.
    Wartman, S. A. (1983) Sexual side effects of antihypertensive drugs. Treatment, strategies and strictures. Postgrad. Med. 73, 133–138.PubMedGoogle Scholar
  22. 22.
    Leyson, J. F. J. (1984) Use of dopaminergic drugs in the treatment of impotence. Presented at the annual meeting of Society for Sex Therapy and Research. New York City, NY. Oct. 19–21.Google Scholar
  23. 23.
    Leyson, J. F. J. (1988) Updates on sexual medicine. Presented at the Annual Winter Meeting of the Association of Philippine Physicians in America, Manila, Phil. Dec. 14–17.Google Scholar
  24. 24.
    Beaumont G. (1973) Sexual side-effect of clomipramine (Anafranil). J. Int. Med. Res. 1, 469–72.Google Scholar
  25. 25.
    Bowers, M. B., Woert, M. V., and Davis, L. (1971) Sexual behavior during L-dopa treatment for Parkinsonism. Amer. J. Psychiat. 127, 1691–1693.PubMedGoogle Scholar
  26. 26.
    Degen, K. (1982) Sexual dysfunction in women using major tranquilizers. Psychosomatics 23, 959–961.PubMedGoogle Scholar
  27. 27.
    Freed, E. (1983) Increased sexual function with nomifensine. Med. J. Australia 2, 538.Google Scholar
  28. 28.
    Gross, M. D. (1982) Reversal by bethanechol of sexual dysfunction caused by anticholinergic antidepressants. Amer. J. Psychiat. 139, 1193, 1194.Google Scholar
  29. 29.
    Lesko, L. M., Stotland, N. L., and Segraves, R. T. (1982) Three cases of female anorgasmia associated with MAOIs. Amer. J. Psychiat. 139, 1353–1354.PubMedGoogle Scholar
  30. 30.
    Malatesta, V. J., Pollack, R. H., Crotty, T. D., and Peacock, L. J. (1982) Acute alcohol intoxication and the female orgasmic response. J. Sex Res. 18, 1–17.CrossRefGoogle Scholar
  31. 31.
    Pierce, J. R. (1983) Cimitidine-associated depression and loss of libido in a woman. Amer. J. Med. Sci. 286, 31–34.PubMedCrossRefGoogle Scholar
  32. 32.
    Quirk, K. C., and Einarson, T. R. (1982) Sexual dysfunction and clomipramine. Can. J. Psychiatry 27, 228–231.PubMedGoogle Scholar
  33. 33.
    Sangal, R. (1985) Inhibited female orgasm as a side effect of alprazolam. Am. J. Psychiat. 142, 1223, 1224.PubMedGoogle Scholar
  34. 34.
    Shalet, S. M. (1980) Effects of cancer chemotherapy on gonadal function of patients. Cancer Treatment Reviews 7, 141–152.PubMedCrossRefGoogle Scholar
  35. 35.
    Shen, W. W. (1982) Female orgasmic inhibition by amoxapine. Am. J. Psychiatry 139, 1220, 1221.PubMedGoogle Scholar
  36. 36.
    Shen, W. W., and Sata, L. S. (1983) Inhibited female orgasm resulting from psychotropic drugs. J. Reproductive Med. 28, 497–499.CrossRefGoogle Scholar
  37. 37.
    Souner R. (1983) Anorgasmia associated with imipramine but not desipramine: A case report. J. Clin. Psychiatry 44, 345–346.Google Scholar
  38. 38.
    Souner, R. (1984) Treatment of tricyclic antidepressant-induced orgasmic inhibition with cyproheptadine. J. Clin. Psychopharm. 4, 169.Google Scholar
  39. 39.
    Wagner, G., and Levin, R. J. (1980) Effect of atropine and methylatropine on human vaginal blood flow, sexual arousal and climax. Acta. Pharmacol. Toxicol. 46, 321–325.CrossRefGoogle Scholar
  40. 40.
    Wallace, T. R., Fraunfelder, F. T., Petursson, G. J., and Epstein, D. L. (1979) Decreased libido—A side effect of carbonic anhydrase inhibitor. Ann. Opthalmol. 237, 1563–1566.Google Scholar
  41. 41.
    Segraves, R., Madsen, R., Carter, S. and Davis, J. (1986) Erectile dysfunction associated with pharmacological agents. In Segraves, R., and Schoenberg, H. (eds.) Diagnosis and Treatment of Erectile Failure. Plenum, New York City, NY.Google Scholar
  42. 42.
    Espir, M. L. E., Hall, J. W., Schirreffs, J. G., Stevens, D. L. (1970) Impotence in farm workers using toxic chemicals. Brit. Med. J. 1, 423–425.PubMedCrossRefGoogle Scholar
  43. 43.
    Layzer, R. B. (1978) Myeloneuropathy after prolonged exposure to nitrous oxide. Lancet 1, 1227–1230.CrossRefGoogle Scholar
  44. 44.
    Crenshaw, T. (1989) Personal communication.Google Scholar

Copyright information

© The Humana Press Inc. 1991

Authors and Affiliations

  • Jose Florante J. Leyson
    • 1
    • 2
  • Robert T. Francoeur
    • 2
  1. 1.University of Medicine and DentistryNewark
  2. 2.Fairleigh Dickinson UniversityMadison

Personalised recommendations